Silo Pharma Announces Positive Initial Pharmacokinetic, Safety, and Tolerability Study of SP-26 for Chronic Pain and Fibromyalgia
No serious side effects or discomfort observed Final safety and absorption data expected in March 2025SARASOTA, FL, Feb. 11, 2025 (GLOBE ...
MAXONA PHARMACEUTICALS EMERGES FROM STEALTH AS IT ACHIEVES MILESTONE IN DEVELOPMENT OF FIRST-TO-MARKET CANDIDATE MAX-001
MAXONA Pharmaceuticals today announced that it has emerged from stealth with the completion of the U.S. Phase 1 clinical ...
Silo Pharma announces initial data from SP-26 study
Silo Pharma (SILO) announced am update from an ongoing study evaluating the pharmacokinetics, safety and tolerability of its novel SP-26 ...
Chemistry World4h
New type of painkiller approved in US
For the first time in decades, a new class of painkiller has been approved by the US Food and Drug Administration (FDA).
Nashville Post16h
Vanderbilt neuroscience researcher awarded $6.2M
A Vanderbilt researcher has been awarded $6.2 million to study the effect of opioids on the brain.